The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study
Open accessAbstract
Background: The relative risk of lung cancer decreases with years since quitting (YSQ) smoking, but risk beyond 25 YSQ remains unclear. Current lung cancer screening guidelines, which exclude smokers with more than 15 YSQ, may not detect lung cancers in this population. Methods: We analyzed data from Framingham Heart Study Original (n = 3905) and Offspring cohort (n = 5002) participants for lifetime smoking and lung cancer incidence from 1954 to 1958 (Exam 4) and 1971 to 1975 (Exam 1), respectively, through 2013. We used multivariable-adjusted Cox proportional hazards regression models to compare current, former, and never smokers and lung cancer risk. Smoking status and covariates were time-updated every two years (Original) or four years (Offspring). Primary analyses were restricted to heavy ever smokers with more than 21.3 pack-years; additional analyses included all ever smokers. Results: On follow-up (median = 28.7 years), 284 lung cancers were detected: incidence rates/1000 person-years in current, former, and never smokers were 1.97 (95% confidence interval [CI] = 1.66 to 2.33), 1.61 (95% CI = 1.34 to 1.93), and 0.26 (95% CI = 0.17 to 0.39), respectively. Heavy former (vs never) smokers had elevated lung cancer risk at all YSQ (<5: hazard ratio [HR] = 12.12, 95% CI = 6.94 to 21.17; 5-9: HR = 11.77, 95% CI = 6.78 to 20.45; 10-14: HR = 7.81, 95% CI = 3.98 to 15.33; 15-24: HR = 5.88, 95% CI = 3.19-10.83; ≥25: HR = 3.85, 95% CI = 1.80 to 8.26). Heavy former (vs current) smokers had 39.1% lower lung cancer risk within five YSQ. Among all former smokers, 40.8% of lung cancers occurred after more than 15 YSQ. Conclusions: Among heavy former smokers, lung cancer risk drops within five YSQ relative to continuing smokers, yet it remains more than threefold higher than never smokers after 25 YSQ. Four of ten lung cancers occurred in former smokers with more 15 YSQ, beyond the screening window of the current guideline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920
Research works printed but not linked: 34
- Tanner, 2016, The association between smoking abstinence and mortality in the National Lung Screening Trial, Am J Respir Crit Care Med., 193, 534, 10.1164/rccm.201507-1420OC · DOI · Paper page
- Lim, 2013, Smoking cessation and mortality among middle-aged and elderly Chinese in Singapore: The Singapore Chinese Health Study, Tob Control., 22, 235, 10.1136/tobaccocontrol-2011-050106 · DOI
- Carreras, 2015, Reduction of risk of dying from tobacco-related diseases after quitting smoking in Italy, Tumori., 101, 657, 10.5301/tj.5000307 · doi:10.5301/tj.5000307
- Doll, 1976, Mortality in relation to smoking: 20 years' observations on male British doctors, BMJ, 2, 1525, 10.1136/bmj.2.6051.1525 · DOI · Paper page
- Hammond, 1966, Smoking in relation to the death rates of one million men and women, Natl Cancer Inst Monogr., 19, 127
- Rogot, 1980, Cancer mortality among nonsmokers in an insured group of U.S. veterans, J Natl Cancer Inst., 65, 1163
- Peto, 2000, Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies, BMJ., 321, 323, 10.1136/bmj.321.7257.323 · DOI · Paper page
- Ebbert, 2003, Lung cancer risk reduction after smoking cessation: Observations from a prospective cohort of women, J Clin Oncol., 21, 921, 10.1200/JCO.2003.05.085 · DOI · Paper page
- Lubin, 1984, Modifying risk of developing lung cancer by changing habits of cigarette smoking, BMJ, 288, 1953, 10.1136/bmj.288.6435.1953 · DOI
- Wong, 2010, Smoking cessation and lung cancer risk in an Asian population: Findings from the Singapore Chinese Health Study, Br J Cancer., 103, 1093, 10.1038/sj.bjc.6605782 · DOI
- Chin, 2015, Screening for lung cancer with low-dose CT—translating science into Medicare coverage policy, N Engl J Med., 372, 2083, 10.1056/NEJMp1502598 · DOI
- US Department of Health and Human Services, 1990, The Health Benefits of Smoking Cessation
- Kuller, 1991, Cigarette smoking and mortality. MRFIT Research Group, Prev Med., 20, 638, 10.1016/0091-7435(91)90060-H · DOI
- Godtfredsen, 2005, Effect of smoking reduction on lung cancer risk, JAMA., 294, 1505, 10.1001/jama.294.12.1505 · DOI · Paper page
- Kreger, 1991, The cancer experience in the Framingham Heart Study cohort, Cancer., 67, 1, 10.1002/1097-0142(19910101)67:1<1::AID-CNCR2820670102>3.0.CO;2-W · doi:10.1002/1097-0142(19910101)67:1<1::aid-cncr2820670102>3.0.co;2-w
- Peto, 2012, That the effects of smoking should be measured in pack-years: Misconceptions 4, Br J Cancer., 107, 406, 10.1038/bjc.2012.97 · DOI
- Pinsky, 2015, Lung cancer risk by years since quitting in 30+ pack year smokers, J Med Screen., 22, 151, 10.1177/0969141315579119 · doi:10.1177/0969141315579119
- Pinsky, 2012, Applying the National Lung Screening Trial eligibility criteria to the US population: What percent of the population and of incident lung cancers would be covered?, J Med Screen., 19, 154, 10.1258/jms.2012.012010 · DOI
- Moyer, 2014, Screening for lung cancer: US Preventive Services Task Force recommendation statement, Ann Intern Med., 160, 330–338, 10.7326/M13-2771 · DOI · Paper page
- Bach, 2012, Benefits and harms of CT screening for lung cancer: A systematic review, JAMA., 307, 2418, 10.1001/jama.2012.5521 · DOI · Paper page
- Humphrey, 2013, Screening for lung cancer with low-dose computed tomography: A systematic review to update the US Preventive services task force recommendation, Ann Intern Med., 159, 411, 10.7326/0003-4819-159-6-201309170-00690 · DOI · Paper page
- Kovalchik, 2013, Targeting of low-dose CT screening according to the risk of lung-cancer death, N Engl J Med., 369, 245, 10.1056/NEJMoa1301851 · DOI · Paper page
- Tammemägi, 2013, Selection criteria for lung-cancer screening, N Engl J Med., 368, 728, 10.1056/NEJMoa1211776 · DOI · Paper page
- Tammemagi, 2014, Evaluation of the lung cancer risks at which to screen ever- and never smokers: Screening rules applied to the PLCO and NLST cohorts, PLoS Med, 11, e1001764, 10.1371/journal.pmed.1001764 · DOI · Paper page
- Khuder, 2001, Effect of smoking cessation on major histologic types of lung cancer, Chest., 120, 1577, 10.1378/chest.120.5.1577 · DOI
- Kenfield, 2008, Comparison of aspects of smoking among the four histological types of lung cancer, Tob Control., 17, 198, 10.1136/tc.2007.022582 · DOI · Paper page
- Baker, 2000, Health risks associated with cigar smoking, JAMA., 284, 735, 10.1001/jama.284.6.735 · DOI · Paper page
- Pershagen, 1994, Residential radon exposure and lung cancer in Sweden, N Engl J Med., 330, 159, 10.1056/NEJM199401203300302 · doi:10.1056/nejm199401203300302
- Lam, 2009, Cruciferous vegetable consumption and lung cancer risk: A systematic review. Cancer, Epidemiol Biomarkers Prev., 18, 184, 10.1158/1055-9965.EPI-08-0710 · DOI · Paper page
- Wassenaar, 2015, CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers—findings from two independent populations, Carcinogenesis., 36, 99, 10.1093/carcin/bgu235 · DOI
- Spira, 2004, Effects of cigarette smoke on the human airway epithelial cell transcriptome, Proc Natl Acad Sci U S A., 101, 10143, 10.1073/pnas.0401422101 · DOI · Paper page
- Beane, 2007, Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression, Genome Biol., 8, R201, 10.1186/gb-2007-8-9-r201 · DOI · Paper page
- Varella-Garcia, 2007, Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer, Am J Respir Crit Care Med., 176, 505, 10.1164/rccm.200609-1329OC · doi:10.1164/rccm.200609-1329oc
- Rahman, 2016, The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer, JCI Insight., 1, e88814, 10.1172/jci.insight.88814 · DOI
Cited by
Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease
Duncan, M. S., Freiberg, M. S., Greevy, R. A., Kundu, S., Vasan, R. S., & Tindle, H. A. (2019) · JAMA · doi:10.1001/jama.2019.10298 · Cited by 398
Self-citationScreening for lung cancer: 2023 guideline update from the American Cancer Society
Wolf, A. M. D., Oeffinger, K. C., Shih, T. Y., Walter, L. C., Church, T. R., Fontham, E. T. H., Elkin, E. B., Etzioni, R. D., Guerra, C. E., Perkins, R. B., et al. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21811 · Cited by 310
Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers
Fowler, H., Belot, A., Ellis, L., Maringe, C., Luque-Fernandez, M. A., Njagi, E. N., Navani, N., Sarfati, D., & Rachet, B. (2020) · BMC Cancer · doi:10.1186/s12885-019-6472-9 · Cited by 270
Lung Cancer—Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature)
Smolarz, B., Łukasiewicz, H., Samulak, D., Piekarska, E., Kołaciński, R., & Romanowicz, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052049 · Cited by 259
Pyrkov, T. V., Avchaciov, K., Tarkhov, A. E., Menshikov, L. I., Gudkov, A. V., & Fedichev, P. O. (2021) · Nature Communications · doi:10.1038/s41467-021-23014-1 · Cited by 139
Metadata
- Authors
- Tindle, H. A., Stevenson Duncan, M., Greevy, R. A., Vasan, R. S., Kundu, S., Massion, P. P., & Freiberg, M. S.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-05-16
- Volume
- 110
- Issue
- 11
- Pages
- 1201-1207
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2803453147
- Cited by
- 208
- References
- 2
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- National Heart, Lung, and Blood Institute
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study. https://app.cochat.ai/papers/10.1093/jnci/djy041
- The paper
- Tindle, H. A., Stevenson Duncan, M., Greevy, R. A., Vasan, R. S., Kundu, S., Massion, P. P., & Freiberg, M. S. (2018). Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djy041
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.